Professor Phillip Darcy

Professor Phillip Darcy


Group Leader, Cancer Immunotherapy Laboratory
Peter MacCallum Cancer Centre
Elected in 2022
Citation on election

Professor Phillip Darcy is an NHMRC Principal Research Fellow and Group Leader at the Peter MacCallum Cancer Centre. His work has been pivotal in developing novel T cell-based immunotherapy approaches for cancer patients. In particular, his studies involving the development of technology using gene‐modified T cells expressing chimeric antigen receptors (CARs) in preclinical models has led to licensing of an international patent to industry partners and underpins five FDA/TGA‐approved therapies for CD19+ blood cancers.

Professor Darcy’s work has also been integral in the first CAR T cell trial undertaken in Australia.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.